These clinical results were hardly reported in ITP but consistent with previous studies beyond ITP, as there has been a reported case of severe drug-induced immune thrombocytopenia (DITP) caused by the selective COX-2 inhibitor etoricoxib [34]. The gene discussed is PTGS2; the disease is autoimmune thrombocytopenic purpura.